Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 1/2007

01.01.2007 | Original Article

Prediction of cervical involvement in endometrial cancer by hysteroscopy

verfasst von: Benny Almog, Guy Gutman, Joseph B. Lessing, Dan Grisaru

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study evaluated the ability of hysteroscopy to preoperatively predict cervical involvement in endometrial cancer.

Methods

The records of 110 surgically staged consecutive endometrial cancer patients treated at our institution from 1997 to 2003 were retrospectively analyzed. Data on demographics, preoperative staging procedures, surgical pathology reports, and adjuvant treatments were retrieved.

Results

Fourteen (12.7%) patients had cervical involvement (stage II) according to the surgical pathology report, of whom nine (8.1%) had stage IIA and five (4.6%) had stage IIB. Clinical evaluation by speculoscopy and palpation had failed to reveal any indication of cervical involvement. Preoperative diagnostic hysteroscopy procedures were included. None of the hysteroscopy procedures revealed any suspicious lesion in the cervical canal.

Conclusion

Hysteroscopy and clinical examination fail to adequately predict cervical involvement in endometrial carcinoma. Fractional D&C appears to be the best method until a more effective alternative becomes available.
Literatur
1.
Zurück zum Zitat Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ (2004) Cancer statistics, 2004. CA Cancer J Clin 54:8–29PubMedCrossRef Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ (2004) Cancer statistics, 2004. CA Cancer J Clin 54:8–29PubMedCrossRef
2.
Zurück zum Zitat Cornelison TL, Trimble EL, Kosary CL (1999) SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988–1994. Gynecol Oncol 74:350–355PubMedCrossRef Cornelison TL, Trimble EL, Kosary CL (1999) SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988–1994. Gynecol Oncol 74:350–355PubMedCrossRef
3.
Zurück zum Zitat Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A, Blessing JA (1984) Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 63:825–832PubMed Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A, Blessing JA (1984) Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 63:825–832PubMed
4.
Zurück zum Zitat Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK (1996) Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 88:394–398PubMedCrossRef Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK (1996) Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 88:394–398PubMedCrossRef
5.
Zurück zum Zitat Kodama S, Kase H, Tanaka K, Matsui K (1996) Multivariate analysis of prognostic factors in patients with endometrial cancer. Int J Gynaecol Obstet 53:23–30PubMed Kodama S, Kase H, Tanaka K, Matsui K (1996) Multivariate analysis of prognostic factors in patients with endometrial cancer. Int J Gynaecol Obstet 53:23–30PubMed
6.
Zurück zum Zitat Ackerman I, Malone S, Thomas G, Franssen E, Balogh J, Dembo A (1996) Endometrial carcinoma-relative effectiveness of adjuvant irradiation vs therapy reserved for relapse. Gynecol Oncol 60:177–183PubMedCrossRef Ackerman I, Malone S, Thomas G, Franssen E, Balogh J, Dembo A (1996) Endometrial carcinoma-relative effectiveness of adjuvant irradiation vs therapy reserved for relapse. Gynecol Oncol 60:177–183PubMedCrossRef
7.
Zurück zum Zitat Babilonti L, Di Pietro G, La Fianza A, Beretta P, Franchi M (1989) Complications of pelvic lymphadenectomy in patients with endometrial adenocarcinoma. Eur J Gynaecol Oncol 10(2):131–133PubMed Babilonti L, Di Pietro G, La Fianza A, Beretta P, Franchi M (1989) Complications of pelvic lymphadenectomy in patients with endometrial adenocarcinoma. Eur J Gynaecol Oncol 10(2):131–133PubMed
8.
Zurück zum Zitat Larson DM, Johnson K, Olson KA (1992) Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Obstet Gynecol 79:998–1001PubMed Larson DM, Johnson K, Olson KA (1992) Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Obstet Gynecol 79:998–1001PubMed
9.
Zurück zum Zitat Benedet JL, Bender H, Jones H III, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70:209–262PubMedCrossRef Benedet JL, Bender H, Jones H III, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70:209–262PubMedCrossRef
10.
Zurück zum Zitat Weiner J, Bigelow B, Demopoulos RI, Beckman EM, Weiner I (1980) The value of endocervical sampling in the staging of endometrial carcinoma. Diagn Gynecol Obstet 2:265–268PubMed Weiner J, Bigelow B, Demopoulos RI, Beckman EM, Weiner I (1980) The value of endocervical sampling in the staging of endometrial carcinoma. Diagn Gynecol Obstet 2:265–268PubMed
11.
Zurück zum Zitat Frauenhoffer EE, Zaino RJ, Wolff TV, Whitney CE (1987) Value of endocervical curettage in the staging of endometrial carcinoma. Int J Gynecol Pathol 6:195–202PubMedCrossRef Frauenhoffer EE, Zaino RJ, Wolff TV, Whitney CE (1987) Value of endocervical curettage in the staging of endometrial carcinoma. Int J Gynecol Pathol 6:195–202PubMedCrossRef
12.
Zurück zum Zitat Rubin SC, Hoskins WJ, Saigo PE, Nori D, Mychalczak B, Chapman D, Lewis JL Jr (1992) Management of endometrial adenocarcinoma with cervical involvement. Gynecol Oncol 45:294–298PubMedCrossRef Rubin SC, Hoskins WJ, Saigo PE, Nori D, Mychalczak B, Chapman D, Lewis JL Jr (1992) Management of endometrial adenocarcinoma with cervical involvement. Gynecol Oncol 45:294–298PubMedCrossRef
13.
Zurück zum Zitat Nahhas WA, Whitney CW, Stryker JA, Curry SL, Chung CK, Mortel R (1980) Stage II endometrial carcinoma. Gynecol Oncol 10:303–311PubMedCrossRef Nahhas WA, Whitney CW, Stryker JA, Curry SL, Chung CK, Mortel R (1980) Stage II endometrial carcinoma. Gynecol Oncol 10:303–311PubMedCrossRef
14.
Zurück zum Zitat Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol 40:55–65PubMedCrossRef Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol 40:55–65PubMedCrossRef
15.
Zurück zum Zitat Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer 60(Suppl 8):2035–2041PubMed Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer 60(Suppl 8):2035–2041PubMed
16.
Zurück zum Zitat Boente MP, Orandi YA, Yordan EL, Miller A, Graham JE, Kirshner C, Wilbanks GD (1995) Recurrence patterns and complications in endometrial adenocarcinoma with cervical involvement. Ann Surg Oncol 2:138–144PubMedCrossRef Boente MP, Orandi YA, Yordan EL, Miller A, Graham JE, Kirshner C, Wilbanks GD (1995) Recurrence patterns and complications in endometrial adenocarcinoma with cervical involvement. Ann Surg Oncol 2:138–144PubMedCrossRef
17.
Zurück zum Zitat Tahir MM, Bigrigg MA, Browning JJ, Brookes ST, Smith PA (1999) A randomized controlled trial comparing transvaginal ultrasound, outpatient hysteroscopy and endometrial biopsy with inpatient hysteroscopy and curettage. Br J Obstet Gynaecol 106:1259–1264PubMed Tahir MM, Bigrigg MA, Browning JJ, Brookes ST, Smith PA (1999) A randomized controlled trial comparing transvaginal ultrasound, outpatient hysteroscopy and endometrial biopsy with inpatient hysteroscopy and curettage. Br J Obstet Gynaecol 106:1259–1264PubMed
18.
Zurück zum Zitat Gimpelson RJ, Rappold HO (1988) A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases. Am J Obstet Gynecol 158:489–492PubMed Gimpelson RJ, Rappold HO (1988) A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases. Am J Obstet Gynecol 158:489–492PubMed
19.
Zurück zum Zitat Ben-Yehuda OM, Kim YB, Leuchter RS (1998) Does hysteroscopy improve upon the sensitivity of dilatation and curettage in the diagnosis of endometrial hyperplasia or carcinoma? Gynecol Oncol 68:4–7PubMedCrossRef Ben-Yehuda OM, Kim YB, Leuchter RS (1998) Does hysteroscopy improve upon the sensitivity of dilatation and curettage in the diagnosis of endometrial hyperplasia or carcinoma? Gynecol Oncol 68:4–7PubMedCrossRef
20.
Zurück zum Zitat Stock RJ, Kanbour A (1975) Prehysterectomy curettage. Obstet Gynecol 45:537–541PubMed Stock RJ, Kanbour A (1975) Prehysterectomy curettage. Obstet Gynecol 45:537–541PubMed
21.
Zurück zum Zitat Kietlinska Z, Stelmachow J, Antczak-Judycka A, Timorek A, Sawicki W, Tyminska B (1998) Fractional curettage, hysteroscopy and imaging techniques: TVS, MRI, and computed tomography (CT) in the diagnosis of cervical canal involvement in cases of endometrial carcinoma. Eur J Gynaecol Oncol 19:561–564PubMed Kietlinska Z, Stelmachow J, Antczak-Judycka A, Timorek A, Sawicki W, Tyminska B (1998) Fractional curettage, hysteroscopy and imaging techniques: TVS, MRI, and computed tomography (CT) in the diagnosis of cervical canal involvement in cases of endometrial carcinoma. Eur J Gynaecol Oncol 19:561–564PubMed
22.
Zurück zum Zitat Lo KW, Cheung TH, Yim SF, Chung TK (2001) Preoperative hysteroscopic assessment of cervical invasion by endometrial carcinoma: a retrospective study. Gynecol Oncol 82:279–282PubMedCrossRef Lo KW, Cheung TH, Yim SF, Chung TK (2001) Preoperative hysteroscopic assessment of cervical invasion by endometrial carcinoma: a retrospective study. Gynecol Oncol 82:279–282PubMedCrossRef
23.
Zurück zum Zitat Toki T, Oka K, Nakayama K, Oguchi O, Fujii S (1998) A comparative study of pre operative procedures to assess cervical invasion by endometrial carcinoma. Br J Obstet Gynaecol 105:512–516PubMed Toki T, Oka K, Nakayama K, Oguchi O, Fujii S (1998) A comparative study of pre operative procedures to assess cervical invasion by endometrial carcinoma. Br J Obstet Gynaecol 105:512–516PubMed
24.
Zurück zum Zitat Morimura Y, Soeda S, Hashimoto T, Takano Y, Ohwada M, Yamada H, Yanagida K, Sato A (2000) The value of pre-operative diagnostic procedures for cervical involvement in uterine corpus carcinoma. Fukushima J Med Sci 46:1–11PubMed Morimura Y, Soeda S, Hashimoto T, Takano Y, Ohwada M, Yamada H, Yanagida K, Sato A (2000) The value of pre-operative diagnostic procedures for cervical involvement in uterine corpus carcinoma. Fukushima J Med Sci 46:1–11PubMed
25.
Zurück zum Zitat Lampe B, Kurzl R, Dimpfl T, Fawzi H (1997) Accuracy of preoperative histology and macroscopic assessment of cervical involvement in endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol 74(2):205–209PubMedCrossRef Lampe B, Kurzl R, Dimpfl T, Fawzi H (1997) Accuracy of preoperative histology and macroscopic assessment of cervical involvement in endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol 74(2):205–209PubMedCrossRef
Metadaten
Titel
Prediction of cervical involvement in endometrial cancer by hysteroscopy
verfasst von
Benny Almog
Guy Gutman
Joseph B. Lessing
Dan Grisaru
Publikationsdatum
01.01.2007
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 1/2007
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-006-0220-5

Weitere Artikel der Ausgabe 1/2007

Archives of Gynecology and Obstetrics 1/2007 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.